Home > Insider Trading > Filing (0001142576-13-000011)

Filing Details

Accession Number:: 0001142576-13-000011
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-04-10 21:59:19
Reporting Period:: 2013-04-08

Filing Date:: 2013-04-10
Accepted Time:: 2013-04-10 21:59:19
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1142576	Optimer Pharmaceuticals Inc	OPTR	Pharmaceutical Preparations (2834)	330830300

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1470741	Pedro Lichtinger	7211 Eads Avenue La Jolla CA 92037		No	No	No	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-04-08	58,000	$11.41	162,078	No	4	M	Direct
Common Stock	Acquisiton	2013-04-08	90,000	$13.51	252,078	No	4	M	Direct
Common Stock	Disposition	2013-04-08	58,000	$14.63	194,078	No	4	S	Direct
Common Stock	Disposition	2013-04-08	90,000	$14.73	104,078	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock option (right to buy)	Disposition	2013-04-08	58,000	$0.00	58,000	$11.41
Common Stock	Stock option (right to buy)	Disposition	2013-04-08	90,000	$0.00	90,000	$13.51

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2013-05-26	No	4	M	Direct
0		2013-05-26	No	4	M	Direct

Footnotes

On January 26, 2011, the reporting person was granted an option to purchase 58,000 shares of common stock. 1/4 of the shares subject to the option vested on January 1, 2012. Thereafter, the remaining shares subject to the option were scheduled to vest and become exercisable in 36 equal montly installments subject to the reporting person continuing to be service provider on each such date. At the time the reporting person's service was terminated in February 2013, the option: (i) had vested as to 30,208 shares; and (ii) was accelerated as to 27,792 shares in accordance with the reporting person's separation agreement.
On February 7, 2012, the reporting person was granted an option to purchase 120,000 shares of common stock. 1/4 of the shares subject to the option vested on February 7, 2013. Thereafter, the remaining shares subject to the option were scheduled to vest and become exercisable in 36 monthly installments subject to the reporting person continuing to be service provider on each such date. At the time the reporting person's service was terminated in February 2013, the option: (i) had vested as to 30,000 shares; (ii) was accelerated as to 60,000 shares in accordance with the reporting person's separation agreement; and (iii) was cancelled as to the remaining 30,000 shares.
Without admitting any legal obligation, the reporting person has agreed to remit to the Company appropriate profits realized for purposes of Section 16(b) of the Securities and Exchange Act of 1934, as amended.